SEC Form 4 · accession 0001638599-17-000527
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy A Springer
Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2017 | P | 518 | $13.75 | A | 16,622 | D | |
| Common StockF1,F2 | holding | — | — | — | 1,237,028 | I | See Footnote | |
| Common StockF1,F3 | holding | — | — | — | 445,576 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1LKST, Inc. is the general partner of Leukon Investments LP. Timothy Springer is the president of LKST, Inc. and the managing member of TAS Partners, LLC. The Reporting Person disclaims beneficial ownership of the securities held by Leukon Investments LP and TAS Partners, LLC except to the extent of his pecuniary interest therein, if any.
- F2Held by Leukon Investments LP.
- F3Held by TAS Partners, LLC.